Evidence map›Paper›PMID 26030398›Full record

ArticleCell cycle (Georgetown, Tex.)2015

p53 checkpoint ablation exacerbates the phenotype of Hinfp dependent histone H4 deficiency.

Prachi N Ghule, Rong-Lin Xie, Jennifer L Colby, Stephen N Jones, Jane B Lian, Andre J van Wijnen, Janet L Stein, Gary S Stein

Open access · bronzeAbstract read
In one paragraph

Article in Cell cycle (Georgetown, Tex.), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Aging · 2022
    Article
  6. Article
  7. Review
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Prachi N Ghulea Department of Biochemistry and University of Vermont Cancer Center ; University of Vermont College of Medicine ; Burlington , VT USA.
Rong-Lin Xie
Jennifer L Colby
Stephen N Jones
Jane B Lian
Andre J van Wijnen
Janet L Stein
Gary S Stein
University of Massachusetts Chan Medical School · USUniversity of Vermont · US

Funding

The Role of MDM Proteins in Cell Growth and TumorigenesisR01CA077735 · NCI · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI JONES, STEPHEN, ZHANG, HONG · 1999 to 2019
$5.7M
Cell Cycle Regulation of Histone Gene ExpressionR01CA139322 · NCI · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI STEIN, GARY S. · 2009 to 2013
$1.6M
NCI NIH HHS R01 CA077735NCI NIH HHS R01 CA139322
6 · The paper itself

Abstract

Histone Nuclear Factor P (HINFP) is essential for expression of histone H4 genes. Ablation of Hinfp and consequential depletion of histones alter nucleosome spacing and cause stalled replication and DNA damage that ultimately result in genomic instability. Faithful replication and packaging of newly replicated DNA are required for normal cell cycle control and proliferation. The tumor suppressor protein p53, the guardian of the genome, controls multiple cell cycle checkpoints and its loss leads to cellular transformation. Here we addressed whether the absence of p53 impacts the outcomes/consequences of Hinfp-mediated histone H4 deficiency. We examined mouse embryonic fibroblasts lacking both Hinfp and p53. Our data revealed that the reduced histone H4 expression caused by depletion of Hinfp persists when p53 is also inactivated. Loss of p53 enhanced the abnormalities in nuclear shape and size (i.e. multi-lobed irregularly shaped nuclei) caused by Hinfp depletion and also altered the sub-nuclear organization of Histone Locus Bodies (HLBs). In addition to the polyploid phenotype resulting from deletion of either p53 or Hinfp, inactivation of both p53 and Hinfp increased mitotic defects and generated chromosomal fragility and susceptibility to DNA damage. Thus, our study conclusively establishes that simultaneous loss of both Hinfp and the p53 checkpoint is detrimental to normal cell growth and may predispose to cellular transformation.

Indexed as

AnimalsCell Cycle CheckpointsCell LineCell ProliferationCell Transformation, NeoplasticChromosome FragilityDNA DamageDNA ReplicationFibroblastsGenomic InstabilityHistonesMiceMice, KnockoutRepressor ProteinsTumor Suppressor Protein p53HiNF-P protein, mouseHistonesRepressor ProteinsTumor Suppressor Protein p53Cell CycleChromosome FragmentationcKO, conditional knockoutdKO, double knockoutHinfpHINFP, Histone Nuclear Factor Phistone H4Histone Locus BodiesHLBs, Histone Locus BodiesMEFs, mouse embryonic fibroblasts.NPATNPAT, Nuclear Protein Ataxia-Telangiectasia locusp53

Identifiers

PMID26030398
PMCPMC4612103
OpenAlexW1835394273

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.